HUTCHMED (China) Ltd (HCM)
18.12
-0.52
(-2.79%)
USD |
NASDAQ |
Jun 14, 16:00
18.13
+0.01
(+0.06%)
After-Hours: 20:00
HUTCHMED Total Assets (Quarterly): 1.280B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.280B |
| June 30, 2023 | 1.297B |
| June 30, 2023 | 1.297B |
| December 31, 2022 | 1.029B |
| June 30, 2022 | 1.194B |
| June 30, 2022 | 1.194B |
| June 30, 2021 | 1.273B |
| June 30, 2021 | 1.273B |
| March 31, 2021 | 693.12M |
| June 30, 2020 | 525.56M |
| June 30, 2020 | 525.56M |
| June 30, 2019 | 495.21M |
| June 30, 2019 | 495.21M |
| March 31, 2019 | 539.30M |
| June 30, 2018 | 577.94M |
| June 30, 2018 | 577.94M |
| December 31, 2017 | 597.93M |
| June 30, 2017 | 344.70M |
| June 30, 2017 | 344.70M |
| December 31, 2016 | 342.44M |
| Date | Value |
|---|---|
| June 30, 2016 | 322.84M |
| June 30, 2016 | 322.84M |
| December 31, 2015 | 229.60M |
| September 30, 2015 | 220.90M |
| June 30, 2015 | 230.37M |
| June 30, 2015 | 230.37M |
| December 31, 2014 | 210.83M |
| June 30, 2014 | 218.02M |
| June 30, 2014 | 218.02M |
| December 31, 2013 | 185.67M |
| June 30, 2013 | 178.47M |
| June 30, 2013 | 178.47M |
| December 31, 2012 | 159.72M |
| June 30, 2012 | 198.95M |
| June 30, 2012 | 198.95M |
| December 31, 2011 | 194.77M |
| December 31, 2010 | 159.93M |
| June 30, 2010 | 143.64M |
| June 30, 2010 | 143.64M |
| December 31, 2009 | 127.75M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
495.21M
Minimum
Jun 2019
1.297B
Maximum
Jun 2023
967.18M
Average
1.194B
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Global Pharmatech Inc | -- |
| Sino Biopharmaceutical Ltd | 8.973B |
| Pharmaron Beijing Co Ltd | 3.058B |
| Regencell Bioscience Holdings Ltd | 12.62M |
| Prenetics Global Ltd | 254.17M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 536.39M |
| Shareholders Equity (Quarterly) | 730.54M |
| Debt to Equity Ratio | 0.1086 |
| Current Ratio | 2.722 |
| Net Debt Paydown Yield | -0.85% |